The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats

International Journal of Developmental Neuroscience

Volumn 22, Issue 5-6, 2004, Pages 379-395

  Zhu, Hongbo ^a,b   Barr, Gordon A ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

AMPA; Dependence; Development; Glutamate; mGlu; Morphine; Opiate; Withdrawal

Indexed keywords

2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR ANTAGONIST; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; WITHDRAWAL SYNDROME;

ADAPTATION, PHYSIOLOGICAL; AGING; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; FEMALE; INJECTIONS, INTRAPERITONEAL; MALE; MORPHINE; MORPHINE DEPENDENCE; NALTREXONE; RATS; RATS, INBRED LEC; RECEPTORS, AMPA; RECEPTORS, METABOTROPIC GLUTAMATE; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 4544317272     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2004.06.005     Document Type: Article

References (90)

1. G.K. Aghajanian, M. Alreja, E.J. Nestler, and J.H. Kogan Dual mechanisms of opiate dependence in the locus coeruleus Clin. Neuropharmacol. 15 Suppl. 1 Pt A 1992 143A 144A
2. G.K. Aghajanian, J.H. Kogan, and B. Moghaddam Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study Brain Res. 636 1994 126 130
3. H. Akaoka, and G. Aston-Jones Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input J. Neurosci. 11 1991 3830 3839
4. R. Anwyl Metabotropic glutamate receptors: electrophysiological properties and role in plasticity Brain Res. Brain Res. Rev. 29 1999 83 120
5. G.A. Barr, and K. Jones Opiate withdrawal in the infant Neurotoxicol. Teratol. 16 1994 219 225
6. G.A. Barr, and H. Zhu Ontogeny of AMPA and metabotropic glutamate receptor mediated morphine withdrawal in the rat Soc. Neurosci. Abstr. 27 2001 224.216
7. J. Bell, and M.W. Adler Comparison of peripheral and central administration of naloxone in precipitating abstinence in morphine-dependent rats Drug Alcohol Depend. 21 1988 189 194
8. J.A. Bell, and C.L. Beglan Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat Eur. J. Pharmacol. 294 1995 297 301
9. J.A. Bell, and C.L. Beglan MK-801 blocks the expression but not the development of tolerance to morphine in the isolated spinal cord of the neonatal rat Eur. J. Pharmacol. 294 1995 289 296
10. A. Bisaga, S.D. Comer, A.S. Ward, P. Popik, H.D. Kleber, and M.W. Fischman The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans Psychophamacology (Berl) 157 2001 1 10
11. S.L. Cappendijk, R. de Vries, and M.R. Dzoljic Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice Eur. Neuropsychopharmacol. 3 1993 111 116
12. S.E. Carden, G.A. Barr, and M.A. Hofer Differential effects of specific opioid receptor antagonists on rat pup isolation calls Brain Res. Dev. Brain Res. 62 1991 17 22
13. M.J. Christie, J.T. Williams, P.B. Osborne, and C.E. Bellchambers Where is the locus in opioid withdrawal? Trends Pharmacol. Sci. 18 1997 134 140
14. J.G. Collins, J.J. Kendig, and P. Mason Anesthetic actions within the spinal cord: contributions to the state of general anesthesia Trends Neurosci. 18 1995 549 553
15. P.J. Conn, and J.P. Pin Pharmacology and functions of metabotropic glutamate receptors Annu. Rev. Pharmacol. Toxicol. 37 1997 205 237
16. J.F. Connaughton, D. Reeser, J. Schut, and L.P. Finnegan Perinatal addiction: outcome and management Am. J. Obstet. Gynecol. 129 1977 679 686
17. R. Dingledine, K. Borges, D. Bowie, and S.F. Traynelis The glutamate receptor ion channels Pharmacol. Rev. 51 1999 7 61
18. E. Fedele, and M. Raiteri In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway Prog. Neurobiol. 58 1999 89 120
19. J. Feng, and J.J. Kendig Selective effects of alfentanil on nociceptive-related neurotransmission in neonatal rat spinal cord Br. J. Anaesth. 74 1995 691 696
20. J.Q. Feng, and J.J. Kendig Propofol potentiates the depressant effect of alfentanil in isolated neonatal rat spinal cord and blocks naloxone-precipitated hyperresponsiveness Neurosci. Lett. 229 1997 9 12
21. L.W. Fitzgerald, J. Ortiz, A.G. Hamedani, and E.J. Nestler Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents J. Neurosci. 16 1996 274 282
22. M. Fitzgerald Developmental biology of inflammatory pain Br. J. Anaesth. 75 1995 177 185
23. M.E. Fundytus, and T.J. Coderre Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence Br. J. Pharmacol. 113 1994 1215 1220
24. M.E. Fundytus, and T.J. Coderre Attenuation of precipitated morphine withdrawal symptoms by acute i.c.v. administration of a group II mGluR agonist Br. J. Pharmacol. 121 1997 511 514
25. M.E. Fundytus, and T.J. Coderre Opioid tolerance and dependence: a new model highlighting the role of metabotropic glutamate receptors Pain Forum 8 1999 3 13
26. M.E. Fundytus, J. Ritchie, and T.J. Coderre Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists Br. J. Pharmacol. 120 1997 1015 1020
27. L.M. Geller, and E.H. Geller A simple technique for the permanent marking of newborn albino rats Psychol. Rep. 18 1966 221 222
28. J.G. Gu, C. Albuquerque, C.J. Lee, and A.B. MacDermott Synaptic strengthening through activation of Ca2+-permeable AMPA receptors Nature 381 1996 793 796
29. B.H. Herman, F. Vocci, and P. Bridge The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction Neuropsychopharmacology 13 1995 269 293
30. J.F. Herrero, J.M. Laird, and J.A. Lopez-Garcia Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog. Neurobiol. 61 2000 169 203
31. D.E. Hutchings Drug abuse during pregnancy: embryopathic and neurobehavioral effects M.C. Braude A.M. Zimmerman Genetic and perinatal effects of abused substances 1987 Academic Press New York 131 151
32. D.E. Hutchings, and D. Dow-Edwards Animal models of opiate, cocaine, and cannabis use Clin. Perinatol. 18 1991 1 22
33. C. Ikonomidou, F. Bosch, M. Miksa, P. Bittigau, J. Vockler, K. Dikranian, T.I. Tenkova, V. Stefovska, L. Turski, and J.W. Olney Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain Science 283 1999 70 74
34. C.E. Inturrisi Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence Sem. Neurosci. 9 1997 110 119
35. M. Ishida, T. Saitoh, K. Shimamoto, Y. Ohfune, and H. Shinozaki A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord Br. J. Pharmacol. 109 1993 1169 1177
36. M.W. Jakowec, A.J. Fox, L.J. Martin, and R.G. Kalb Quantitative and qualitative changes in AMPA receptor expression during spinal cord development Neuroscience 67 1995 893 907
37. M.W. Jakowec, L. Yen, and R.G. Kalb In situ hybridization analysis of AMPA receptor subunit gene expression in the developing rat spinal cord Neuroscience 67 1995 909 920
38. C.G. Jang, R.W. Rockhold, and I.K. Ho An autoradiographic study of [3H]AMPA receptor binding and in situ hybridization of AMPA sensitive glutamate receptor A (GluR-A) subunits following morphine withdrawal in the rat brain Brain Res. Bull. 52 2000 217 221
39. K.L. Jones, and G.A. Barr Ontogeny of morphine withdrawal in the rat Behav. Neurosci. 109 1995 1189 1198
40. K.L. Jones, and G.A. Barr Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat Synapse 39 2001 139 151
41. G.A. Kerkut, and J. Bagust The isolated mammalian spinal cord Prog. Neurobiol. 46 1995 1 48
42. B. Kest, G. McLemore, B. Kao, and C.E. Inturrisi The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids J. Pharmacol. Exp. Ther. 283 1997 1249 1255
43. A.E. King, J.A. Lopez-Garcia, and M. Cumberbatch Antagonism of synaptic potentials in ventral horn neurones by 6-cyano-7- nitroquinoxaline-2,3-dione: a study in the rat spinal cord in vitro Br. J. Pharmacol. 107 1992 375 381
44. A. Klodzinska, E. Chojnacka-Wojcik, A. Palucha, P. Branski, P. Popik, and A. Pilc Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models Neuropharmacology 38 1999 1831 1839
45. H. Koyuncuoglu The combination of tizanidine markedly improves the treatment with dextromethorphan of heroin addicted outpatients Int. J. Clin. Pharmacol. Ther. 33 1995 13 19
46. H. Koyuncuoglu, M. Gungor, H. Sagduyu, and F. Aricioglu Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats Pharmacol. Biochem. Behav. 35 1990 829 832
47. R. Maldonado, S. Negus, and G.F. Koob Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists Neuropharmacology 31 1992 1231 1241
48. J. Mao NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity Brain Res. Brain Res. Rev. 30 1999 289 304
49. G.L. McLemore, B. Kest, and C.E. Inturrisi The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence Brain Res. 778 1997 120 126
50. R.J. Miller Presynaptic receptors Annu. Rev. Pharmacol. Toxicol. 38 1998 201 227
51. R.L. Naeye, W. Blanc, W. Leblanc, and M.A. Khatamee Fetal complications of maternal heroin addiction: abnormal growth, infections, and episodes of stress J. Pediatr. 83 1973 1055 1061
52. E.J. Nestler Molecular basis of long-term plasticity underlying addiction Nat. Rev. Neurosci. 2 2001 119 128
53. E.J. Nestler, and J.F. Tallman Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus Mol. Pharmacol. 33 1988 127 132
54. M. Otsuka, and S. Konishi Electrophysiology of mammalian spinal cord in vitro Nature 252 1974 733 734
55. S. Ozawa, H. Kamiya, and K. Tsuzuki Glutamate receptors in the mammalian central nervous system Prog. Neurobiol. 54 1998 581 618
56. D.E. Pellegrini-Giampietro, M.V. Bennett, and R.S. Zukin Are Ca(2+)-permeable kainate/AMPA receptors more abundant in immature brain? Neurosci. Lett. 144 1992 65 69
57. R.S. Petralia, Y.X. Wang, A.S. Niedzielski, and R.J. Wenthold The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations Neuroscience 71 1996 949 976
58. J.P. Pin, and R. Duvoisin The metabotropic glutamate receptors: structure and functions Neuropharmacology 34 1995 1 26
59. P. Popik, E. Kozela, and A. Pilc Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice Br. J. Pharmacol. 130 2000 1425 1431
60. K. Rasmussen Afferent effects on locus coeruleus in opiate withdrawal Prog. Brain Res. 88 1991 207 216
61. K. Rasmussen The role of the locus coeruleus and N-methyl-d-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal Neuropsychopharmacology 13 1995 295 300
62. K. Rasmussen, and G.K. Aghajanian Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis Brain Res. 505 1989 346 350
63. K. Rasmussen, W.T. Kendrick, J.H. Kogan, and G.K. Aghajanian A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal Neuropsychopharmacology 15 1996 497 505
64. K. Rasmussen, J.H. Krystal, and G.K. Aghajanian Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration Psychopharmacology (Berl) 105 1991 508 512
65. D.E. Redmond Jr., and J.H. Krystal Multiple mechanisms of withdrawal from opioid drugs Annu. Rev. Neurosci. 7 1984 443 478
66. M.I. Rosen, T.J. McMahon, S.W. Woods, H.R. Pearsall, and T.R. Kosten A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal Eur. J. Pharmacol. 307 1996 251 257
67. F.M. Ross, J. Cassidy, M. Wilson, and S.N. Davies Developmental regulation of hippocampal excitatory synaptic transmission by metabotropic glutamate receptors Br. J. Pharmacol. 131 2000 453 464
68. M.J. Sepulveda, L. Hernandez, P. Rada, S. Tucci, and E. Contreras Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study Pharmacol. Biochem. Behav. 60 1998 255 262
69. S.K. Sharma, W.A. Klee, and M. Nirenberg Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance Proc. Natl. Acad. Sci. U. S. A. 72 1975 3092 3096
70. S. Suresh, and K.J. Anand Opioid tolerance in neonates: a state-of-the-art review Paediatr. Anaesth. 11 2001 511 521
71. J.R. Taylor, L.J. Punch, and J.D. Elsworth A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat Psychopharmacology (Berl) 138 1998 133 142
72. S.W. Thompson, G. Gerber, L.G. Sivilotti, and C.J. Woolf Long duration ventral root potentials in the neonatal rat spinal cord in vitro; the effects of ionotropic and metabotropic excitatory amino acid receptor antagonists Brain Res. 595 1992 87 97
73. S.W. Thompson, L. Urban, and A. Dray Contribution of NK1 and NK2 receptor activation to high threshold afferent fibre evoked ventral root responses in the rat spinal cord in vitro Brain Res. 625 1993 100 108
74. S.N. Thorat, M.J. Barjavel, G.A. Matwyshyn, and H.N. Bhargava Comparative effects of NG-monomethyl-l-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice Brain Res. 642 1994 153 159
75. S.R. Thornton, and F.L. Smith Characterization of neonatal rat fentanyl tolerance and dependence J. Pharmacol. Exp. Ther. 281 1997 514 521
76. S.R. Thornton, A.F. Wang, and F.L. Smith Characterization of neonatal rat morphine tolerance and dependence Eur. J. Pharmacol. 340 1997 161 167
77. S. Tokuyama, and I.K. Ho Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats Brain Res. 722 1996 212 216
78. S. Tokuyama, H. Wakabayashi, and I.K. Ho Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome Eur. J. Pharmacol. 295 1996 123 129
79. K.A. Trujillo Effects of noncompetitive N-methyl-d-aspartate receptor antagonists on opiate tolerance and physical dependence Neuropsychopharmacology 13 1995 301 307
80. K.A. Trujillo Cellular and molecular mechanisms of opioid tolerance and dependence: progress and pitfalls Pain Forum 8 1999 29 33
81. J. Vandergriff, and K. Rasmussen The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal Neuropharmacology 38 1999 217 222
82. O.Y. Vekovischeva, D. Zamanillo, O. Echenko, T. Seppala, M. Uusi-Oukari, A. Honkanen, P.H. Seeburg, R. Sprengel, and E.R. Korpi Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits J. Neurosci. 21 2001 4451 4459
83. G.S. Wilson, R. McCreary, J. Kean, and J.C. Baxter The development of preschool children of heroin-addicted mothers: a controlled study Pediatrics 63 1979 135 141
84. R.T. Windh, P.J. Little, and C.M. Kuhn The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies J. Pharmacol. Exp. Ther. 273 1995 1361 1374
85. S. Zeman, and D. Lodge Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro Br. J. Pharmacol. 106 1992 367 372
86. T. Zhang, Y. Feng, R.W. Rockhold, and I.K. Ho Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat Life Sci. 55 1994 L25 L31
87. H. Zhu, and G.A. Barr Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists Psychopharmacology (Berl) 150 2000 325 336
88. H. Zhu, and G.A. Barr Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent Synapse 40 2001 282 293
89. H. Zhu, and G.A. Barr Opiate withdrawal during development: are NMDA receptors indispensable? Trends Pharmacol. Sci. 22 2001 404 408
90. H. Zhu, and G.A. Barr Ontogeny of NMDA receptor-mediated morphine tolerance in the postnatal rat Pain 104 2003 437 447